InfuSystems Holdings Inc (INFU)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
Market Cap: $294.89M
Last updated: Nov 17, 2026 at 11:05 AM ET
InfuSystems Holdings Inc (INFU) P/E Ratio & Valuation History
InfuSystems Holdings (INFU) trades at 29.6x trailing earnings and 2.0x sales. Its P/E of 29.6x is below its 5-year median of 96.1x. Its forward P/E is 30.0x. The median P/E across 4 similar companies is 23.9x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 1.3% lower over the next year. Its free cash flow yield is 8.4%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 29.6x |
| Forward P/E | 30.0x |
| Price to sales | 2.0x |
| Price to book | 4.6x |
| EV/EBITDA | 11.2x |
| Price to FCF | 11.9x |
| EV/FCF | 12.4x |
| PEG | 1.7 |
| FCF yield | 8.4% |
Historical Medians
Against its 10-year medians, its P/S is 42.9% above 1.4x and its P/B is 21.1% above 3.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 29.6x | 96.1x | N/A |
| P/S | 2.0x | 1.5x | 1.4x |
| P/B | 4.6x | 3.5x | 3.8x |
Valuation History
Over the 7 of the 10 year ends shown that have a P/E, its P/E ranged from 17.9x in 2025 to 868.0x in 2022. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $8.97 | 17.9x | 1.3x | 3.3x |
| 2024 | $8.45 | 46.8x | 1.3x | 3.2x |
| 2023 | $10.54 | 113.0x | 1.8x | 4.4x |
| 2022 | $8.68 | 868.0x | 1.6x | 3.9x |
| 2021 | $17.03 | 212.9x | 3.5x | 7.8x |
| 2020 | $18.78 | 23.2x | 3.9x | 10.0x |
| 2019 | $8.53 | 142.2x | 2.1x | 8.1x |
| 2018 | $3.44 | N/A | 1.1x | 3.3x |
| 2017 | $2.30 | N/A | 0.7x | 1.7x |
| 2016 | $2.55 | N/A | 0.8x | 1.1x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INFU
What is INFU's forward P/E ratio?
InfuSystems Holdings has a forward P/E ratio of 30.0x.
Is INFU stock overvalued?
GNG's valuation label for INFU is Fairly valued. Its P/E of 29.6x compares with a median of 23.9x across 4 similar companies.
What is INFU's price to sales ratio?
InfuSystems Holdings has a price to sales ratio of 2.0x.
What is InfuSystems Holdings's average P/E ratio over 5 years?
InfuSystems Holdings's median P/E over the last 5 years is 96.1x, from 56 month-end values through Oct 2026.
What is INFU's PEG ratio?
InfuSystems Holdings has a PEG ratio of 1.7.
INFU pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors